Sakuraba A - Search Results

1

Outcome of elective switching to vedolizumab in inflammatory bowel disease patients under tumor necrosis factor antagonist-maintained clinical remission.

Wang Y, Wang J, Pekow J, Dalal S, Cohen RD, Ollech J, Israel A, Shogan BD, Micic D, Cannon L, Umanskiy K, Hurst R, Hyman N, Rubin DT, Sakuraba A. Wang Y, et al. Among authors: sakuraba a. J Gastroenterol Hepatol. 2019 Dec;34(12):2090-2095. doi: 10.1111/jgh.14751. Epub 2019 Jun 28. J Gastroenterol Hepatol. 2019. PMID: 31169926

2

Animal models of inflammatory bowel disease.

Hibi T, Ogata H, Sakuraba A. Hibi T, et al. Among authors: sakuraba a. J Gastroenterol. 2002;37(6):409-17. doi: 10.1007/s005350200060. J Gastroenterol. 2002. PMID: 12108674 Review. No abstract available.

3

Is there a role for apheresis in gastrointestinal disorders?

Hibi T, Sakuraba A. Hibi T, et al. Among authors: sakuraba a. Nat Clin Pract Gastroenterol Hepatol. 2005 May;2(5):200-1. doi: 10.1038/ncpgasthep0168. Nat Clin Pract Gastroenterol Hepatol. 2005. PMID: 16265186 No abstract available.

4

Natalizumab in Crohn's disease: results from a US tertiary inflammatory bowel disease center.

Sakuraba A, Keyashian K, Correia C, Melek J, Cohen RD, Hanauer SB, Rubin DT. Sakuraba A, et al. Inflamm Bowel Dis. 2013 Mar;19(3):621-6. doi: 10.1097/MIB.0b013e31827eea78. Inflamm Bowel Dis. 2013. PMID: 23429449 Free PMC article.

5

Efficacy and safety of medical therapy for low bone mineral density in patients with inflammatory bowel disease: a meta-analysis and systematic review.

Melek J, Sakuraba A. Melek J, et al. Among authors: sakuraba a. Clin Gastroenterol Hepatol. 2014 Jan;12(1):32-44.e5. doi: 10.1016/j.cgh.2013.08.024. Epub 2013 Aug 24. Clin Gastroenterol Hepatol. 2014. PMID: 23981521 Review.

6

Mucosal healing is associated with improved long-term outcome of maintenance therapy with natalizumab in Crohn's disease.

Sakuraba A, Annunziata ML, Cohen RD, Hanauer SB, Rubin DT. Sakuraba A, et al. Inflamm Bowel Dis. 2013 Nov;19(12):2577-83. doi: 10.1097/MIB.0b013e3182a8df32. Inflamm Bowel Dis. 2013. PMID: 24132161

7

Prevalence of Antibodies Against JC Virus in Patients With Refractory Crohn's Disease and Effects of Natalizumab Therapy.

Bellaguarda E, Keyashian K, Pekow J, Rubin DT, Cohen RD, Sakuraba A. Bellaguarda E, et al. Among authors: sakuraba a. Clin Gastroenterol Hepatol. 2015 Nov;13(11):1919-25. doi: 10.1016/j.cgh.2015.05.022. Epub 2015 May 19. Clin Gastroenterol Hepatol. 2015. PMID: 26001336 Free PMC article.

8

Parastomal Variceal Bleeding Attributed to Obstructive Pathology Successfully Treated by Percutaneous Variceal Embolization.

Tomizawa Y, Sakuraba A, Pekow J. Tomizawa Y, et al. Among authors: sakuraba a. ACG Case Rep J. 2014 Jul 8;1(4):217-9. doi: 10.14309/crj.2014.58. eCollection 2014 Jul. ACG Case Rep J. 2014. PMID: 26157881 Free PMC article.

9

Approach to Optimize Anti-TNF-α Therapy in Patients With IBD.

Komaki Y, Komaki F, Sakuraba A, Cohen R. Komaki Y, et al. Among authors: sakuraba a. Curr Treat Options Gastroenterol. 2016 Mar;14(1):83-90. doi: 10.1007/s11938-016-0079-x. Curr Treat Options Gastroenterol. 2016. PMID: 26872815

10

Age of Diagnosis is Associated with Disease Presentation and Therapeutic Complications in Patients with Crohn's Disease.

Saad AM, Czul F, Sakuraba A, Rubin DT, Cohen RD. Saad AM, et al. Among authors: sakuraba a. Inflamm Bowel Dis. 2016 May;22(5):1027-31. doi: 10.1097/MIB.0000000000000732. Inflamm Bowel Dis. 2016. PMID: 26919459

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

154 results

Search Page

Filters